Day: July 2, 2025

Proceeds to drive development of ONP-002, the Company’s lead intranasal drug candidate for mild traumatic brain injury SARASOTA, Fla., July 02, 2025 (GLOBE NEWSWIRE) — Oragenics, Inc. (NYSE American: OGEN), a clinical-stage biotechnology company pioneering intranasal therapeutics for neurological disorders, today announced the successful closing of its previously announced public offering of Series H Convertible Preferred Stock and Warrants. The Company secured total gross proceeds of approximately $16.5 million. As part of the transaction, Oragenics issued 660,000 shares of its Series H Convertible Preferred Stock, no par value, together with Warrants to purchase up to 660,000 additional shares of Series H Convertible Preferred Stock. Each unit, consisting of one share of Preferred Stock and one Warrant, was sold at a combined...

Mr. Sanghi Has Been Serving in Such Roles on an Interim Basis Since November 2024 CHANDLER, Ariz., July 02, 2025 (GLOBE NEWSWIRE) — (NASDAQ: MCHP) – Microchip Technology Incorporated, a leading provider of smart, connected, and secure embedded control solutions, today announced that Steve Sanghi has agreed to continue to serve as the company’s Chief Executive Officer and President on a permanent basis.  Mr. Sanghi had been serving in such roles on an interim basis since November 2024.  Mr. Sanghi will also continue to serve as Chair of the Microchip Board of Directors.  Prior to his retirement as Microchip’s CEO in 2021, Mr. Sanghi had served as Microchip’s CEO for almost 30 years. Microchip’s lead independent director, Matthew Chapman, stated that “The Board is delighted that Steve has agreed to continue as CEO and President on...

HAMILTON, N.J., July 02, 2025 (GLOBE NEWSWIRE) — First Bank (Nasdaq Global Market: FRBA) invites participation in a conference call to discuss the Company’s financial and operating performance during its second quarter ending on June 30, 2025.Event:       Earnings Conference Call – Second Quarter 2025         When:   Wednesday, July 23, 2025 at 9:00 a.m. Eastern Time         Access:   Conference Call Dial-In:       (800) 715-9871 (toll free)             Conference Call Access Code:   3909613         Patrick L. Ryan, President and Chief Executive Officer, Andrew L. Hibshman, Chief Financial Officer, Peter J. Cahill, Chief Lending Officer, and Darleen Gillespie, Chief Retail Banking Officer will provide an overview of second quarter 2025 results. The management presentation typically lasts approximately...

SASKATOON, Saskatchewan, July 02, 2025 (GLOBE NEWSWIRE) — PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) has granted a total of 827,603 options to purchase common ‎shares to directors, officers, employees and consultants of the Corporation, with an exercise price of $0.48 and ‎an expiry date of July 1, 2035, subject to approval of the TSX Venture Exchange. The Corporation relied on section 5.5(b) of Multilateral Instrument 61-‎‎101 as the exemption from ‎the formal valuation requirements of MI 61-101 in respect of the grant of ‎options to the directors and officers of ‎the Corporation, as the common shares of the Corporation are not ‎listed on a specified market (and ‎the common shares are only listed on the TSXV). ‎The Corporation relied on ‎section 5.7(a) of MI 61-101 as the exemption from the minority approval...

MARIETTA, Pa., July 02, 2025 (GLOBE NEWSWIRE) — Donegal Group Inc. (NASDAQ:DGICA) and (NASDAQ:DGICB) announced today that it plans to release its results for second quarter ended June 30, 2025, on Thursday, July 24, 2025, before the opening of regular trading on the NASDAQ Stock Market. The Company will provide a supplemental investor presentation in the Investors section of its website at investors.donegalgroup.com, concurrently with its earnings press release. At approximately 8:30 am ET on Thursday, July 24, 2025, the Company will make available in the Investors section of its website a pre-recorded audio webcast featuring management commentary by Kevin Burke, President and Chief Executive Officer; Jeffrey Miller, Executive Vice President and Chief Financial Officer; and select members of the senior management team. Management...

LAKEWOOD, Colo., July 02, 2025 (GLOBE NEWSWIRE) — Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the first quarter of fiscal year 2026 at approximately 8:00 A.M. Eastern time on Tuesday, August 5, 2025. About Mesa Laboratories, Inc. Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Mesa offers products and services to help our customers ensure product integrity, increase patient and worker safety, and improve the quality of life throughout the world. CONTACT: Gary Owens, President and CEO, or John Sakys, CFO, both of Mesa Laboratories, Inc., +1-303-987-8000 For more information about the Mesa, please visit our website at www.mes...

Palo Alto, California, July 02, 2025 (GLOBE NEWSWIRE) — NMP Acquisition Corp. (Nasdaq: NMPAU) (the “Company”) today announced the closing of its previously announced initial public offering of 10,000,000 units (the “Offering”) at an offering price of $10.00 per unit, with each unit consisting of one Class A ordinary share and one right. Each right entitles the holder to receive one-fifth (1/5) of one Class A ordinary share upon consummation of the Company’s initial business combination. The units began trading on the Nasdaq Global Market (“Nasdaq”) under the ticker symbol “NMPAU” on July 1, 2025. Once the securities comprising the units begin separate trading, the Class A ordinary shares and rights are expected to trade on Nasdaq under the symbols “NMP” and “NMPAR,” respectively. Maxim Group LLC acted as the sole book-running...

At the initiative and by the decision of the Board of AUGA group, RAB (code 126264360, address Konstitucijos ave. 21C, Vilnius, the “Company”), it has been decided to revoke the extraordinary General Meeting of Shareholders convened on July 14, 2025, following the decision of the Vilnius Regional Court to extend the deadline for submitting the Company’s restructuring plan for Court approval until August 19, 2025. This Court decision was based on unresolved issues regarding the contested creditor claims in the Company’s restructuring case, which currently prevent the creditors from making decisions in accordance with the Law on Legal Entities’ Insolvency (hereinafter referred to as the “Insolvency Law“). As previously announced, the Court ruling of April 22, 2025, which confirmed part of the creditors’...

Dubai, July 2, 2025: VEON Ltd. (Nasdaq: VEON), a global digital operator (“VEON”), announces today that it has completed the pricing of a private placement of USD 200 million of senior unsecured notes due in 2029 with institutional investors (the “Notes”), following its announcement on June 16, 2025 that it is considering options to raise external financing through a private placement. The Notes, issued by VEON MidCo B.V., are priced at par and have an annual interest rate of 9.000%. The instrument’s expected credit rating from S&P and Fitch is BB-. The Notes will be guaranteed by VEON Amsterdam B.V. and will rank pari passu with VEON HQ’s outstanding debt. VEON CFO Burak Ozer said: “This successful new private placement marks another important milestone in VEON’s renewed capital markets story, and I am pleased to note investors’...

Advantage Solutions ranks No. 9 in North America and No. 18 on the global list ST. LOUIS, July 02, 2025 (GLOBE NEWSWIRE) — Advantage Solutions Inc. (NASDAQ: ADV) ranks as the 9th largest agency company in North America and No. 18 worldwide, according to the Ad Age Agency Report 2025. With revenue of $1.2 billion in 2024, Advantage was one of only two Midwest-based agencies in the top 25 list, which is based on worldwide revenue. “Our agency work is one of the many ways we’re shaping how people shop and building momentum in the marketplace. We continue to deliver for our clients and customers, infusing high-tech, high-touch, high-value solutions with the creativity and artistry to bring campaigns to life,” says Advantage CEO Dave Peacock. The Ad Age Agency Report, which evaluates the state of the agency market and includes listings...